PCSK9: From Nature's Loss to Patient's Gain

Circulation. 2024 Jan 16;149(3):171-173. doi: 10.1161/CIRCULATIONAHA.123.064498. Epub 2024 Jan 16.

Authors

Helen H Hobbs^{1

2

3}, Jonathan C Cohen^{2

4}, Jay D Horton^{2

3

4}

Affiliations

¹ Howard Hughes Medical Institute (H.H.H.), University of Texas Southwestern Medical Center, Dallas.
² Departments of Internal Medicine (H.H.H., J.C.C., J.D.H.), University of Texas Southwestern Medical Center, Dallas.
³ Molecular Genetics (H.H.H., J.D.H.), University of Texas Southwestern Medical Center, Dallas.
⁴ Center for Human Nutrition (J.C.C., J.D.H.), University of Texas Southwestern Medical Center, Dallas.

No abstract available

Keywords: Editorials; LDL; LDL receptor; atherosclerosis; cholesterol; natural selection; proprotein convertase.

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Cholesterol, LDL
Humans
Proprotein Convertase 9* / genetics
Receptors, LDL
Serine Endopeptidases*

Substances

PCSK9 protein, human
Proprotein Convertase 9
Serine Endopeptidases
Cholesterol, LDL
Receptors, LDL

Grants and funding